Information about Firazyr (Icatibant)
Firazyr is an injectable medication that contains icatibant, a selective bradykinin B2 receptor antagonist. It is primarily used for the treatment of acute attacks of hereditary angioedema, a genetic condition that causes episodes of severe swelling.
Product Highlights
- Targets the bradykinin pathway, directly addressing the underlying cause of angioedema.
- Management of acute attacks of hereditary angioedema in adults.
Key Ingredient
Key Benefits
- Alleviates symptoms of angioedema within hours.
- Helps individuals manage their condition and reduce the severity of attacks.
- Reduces the frequency and severity of swelling episodes.
Direction of Use
- Ensure that you are in a clean and comfortable environment.
- Choose an appropriate site for subcutaneous injection, such as the abdomen or thigh.
- Follow the instructions provided by your healthcare provider for proper injection technique.
- Observe for any immediate reactions and note any changes in symptoms.
Safety Concerns
- May cause local irritation, redness, or pain at the injection site.
- Risk of hypersensitivity; monitor for signs of severe allergic reactions.
- Patients should be aware of their condition and the appropriate use of the medication.
Avoid Firazyr (Icatibant) If
- You have a known allergy to icatibant or any of its components.
- You are experiencing severe swelling affecting your airway, as Firazyr is not indicated for such situations.
- You have a history of serious allergic reactions to similar medications.
